Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers

被引:0
|
作者
Bhateja, Priyanka [1 ]
Liu, Xuefeng [2 ]
Baliga, Sujith [3 ]
Gogineni, Emile [3 ]
Jhawar, Sachin [3 ]
Mitchell, Darrion [3 ]
Ma, Sungjun [3 ]
Zhu, Simeng [3 ]
Konieczkowski, David [3 ]
Blakaj, Dukagjin [3 ]
Old, Matthew [4 ]
Rocco, James [4 ]
Bonomi, Marcelo [1 ]
机构
[1] Ohio State Univ, James Canc Ctr, Dept Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Dept Pathol, Columbus, OH USA
[3] Ohio State Univ, James Canc Ctr, Dept Radiat Oncol, Columbus, OH USA
[4] Ohio State Univ, James Canc Ctr, Dept Otolaryngol, Columbus, OH USA
关键词
cellular effect; genomic instability; human papillomavirus; oncogenesis; proto-oncogenes; virus classification; HEAD;
D O I
10.1002/jmv.70086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been under-recognized. We describe a case series of 6 metastatic/locoregionally recurrent HPVOPSCC patients with FGFR alterations. HPVOPSCC presents with distinct pattern of spread both temporally and sites of recurrence compared to non-HPV-related oropharyngeal cancer. Identification and reporting of genomic alterations in HPV are crucial to the understanding of disease biology and could aid in development of novel therapeutics for these patients. In addition, use of circulating tumor DNA may lead to early detection and supplement imaging in the follow up of these patients. Loco-regional treatments may also play a key role in the management of metastatic HPV OPSCC depending on the pattern of presentation. Our case series highlights all these novelties that could lead to better treatment outcomes.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
    Jang, JH
    Shin, KH
    Park, JG
    CANCER RESEARCH, 2001, 61 (09) : 3541 - 3543
  • [32] Clinicopathologic characterization and comprehensive genomic profiling (CGP) of advanced breast cancer patients with fibroblast growth factor receptor (FGFR) alterations
    Alvarez, R. H.
    Thomas, J. W.
    Kramer, K.
    Niu, J.
    Ahn, E.
    McKnight, J. E.
    Dhillon, N.
    Pabbathi, H.
    Johnson, A. T.
    Wang, K.
    Ross, J. S.
    Miller, V. A.
    Stephens, P. J.
    Daneker, G. W.
    Ali, S.
    Markman, M.
    CANCER RESEARCH, 2016, 76
  • [33] Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
    Giri, D
    Ropiquet, F
    Ittmann, M
    CLINICAL CANCER RESEARCH, 1999, 5 (05) : 1063 - 1071
  • [34] Impact of oncogenic fibroblast growth factor receptor (FGFR) alterations in patients with advanced solid tumors in a real-world setting
    Sweiti, H.
    Demirdjian, L.
    Triantos, S.
    Standish, K.
    Thomas, S.
    Greshock, J.
    Xia, Q.
    Paone, J.
    Sheridan, P.
    Pant, S.
    Massard, C.
    Reardon, D. A.
    Loriot, Y.
    Schuler, M. H. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S259 - S259
  • [35] Aberrant fibroblast growth factor receptor signaling in bladder and other cancers
    Chaffer, Christine L.
    Dopheide, Bonnie
    Savagner, Pierre
    Thompson, Erik W.
    Williams, Elizabeth D.
    DIFFERENTIATION, 2007, 75 (09) : 831 - 842
  • [36] Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor
    Maroun Bou Zerdan
    Gennady Bratslavsky
    Joseph Jacob
    Jeffrey Ross
    Richard Huang
    Alina Basnet
    Molecular Diagnosis & Therapy, 2023, 27 : 475 - 485
  • [37] Alterations in fibroblast growth factor receptor expression following brain injury
    Reilly, JF
    Kumari, VG
    EXPERIMENTAL NEUROLOGY, 1996, 140 (02) : 139 - 150
  • [38] The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2020, 151
  • [39] Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor
    Bou Zerdan, Maroun
    Bratslavsky, Gennady
    Jacob, Joseph
    Ross, Jeffrey
    Huang, Richard
    Basnet, Alina
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (04) : 475 - 485
  • [40] Fibroblast growth factor receptor 3 (FGFR3) expression in malignant lymphomas
    Larson, Andrew
    Cook, James R.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (04) : 322 - 325